☆ 4.7 Letter

Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia

ANNALS OF INTERNAL MEDICINE (2014)

Journal

ANNALS OF INTERNAL MEDICINE

Volume 161, Issue 8, Pages 613-613

Publisher

AMER COLL PHYSICIANS

DOI: 10.7326/L14-5020-4

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Obstetrics & Gynecology

Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations?

Rebecca Horgan, Yara Hage Diab, Jerri Waller, Alfred Abuhamad, George Saade

Summary: The dosage and timing of aspirin initiation are crucial for reducing the risk of preeclampsia. Initiating a dosage of >100 mg of aspirin daily before 16 weeks' gestation seems to be the most effective approach. Randomized control trials are needed to evaluate the safety and efficacy of different aspirin dosages available in the United States.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study

Qiongjie Zhou, Xingzhong Zhao, Jinghui Xu, Yu Xiong, Jon F. R. Barrett, Xing-Ming Zhao, Xiaotian Li

Summary: This retrospective study aimed to describe the frequency of preeclampsia and aspirin use in real-world practice among women with twin pregnancies. The results showed that the use of low-dose aspirin was associated with a higher incidence of preeclampsia, possibly due to poor compliance with the medication. Further randomized controlled trials or prospective cohort studies are needed.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Add to Collection

Article Obstetrics & Gynecology

Physician's Knowledge and Practices Surrounding Low-Dose Aspirin for Preeclampsia Risk Reduction

L. Carolina Martinez-King, Michael Machiorlatti, Tony Ogburn, Jennifer Salcedo

Summary: This study aimed to evaluate physicians' knowledge and practices regarding the use of low-dose aspirin for preeclampsia risk reduction. The survey results showed that although over 90% of physicians recommended low-dose aspirin, there were gaps in knowledge and differences in practices. Enhanced screening tools and tailored medical education are needed to identify patients who may benefit from this intervention.

AMERICAN JOURNAL OF PERINATOLOGY (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis

Li Zheng, Binbin Xia, Yuan Yuan, Yuran Wang, Yan Wang

Summary: This systematic review examines the efficacy and safety of combining low-molecular-weight heparin (LMWH) or unfractionated heparin with low-dose aspirin (LDA) in preventing preeclampsia in high-risk women. The meta-analysis of 14 randomized controlled trials found that the addition of LMWH to LDA reduces the risk of preeclampsia, small-for-gestational age, fetal and neonatal death, and gestational hypertension without increasing the risk of bleeding. However, larger studies are needed to further validate these findings.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Obstetrics & Gynecology

Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention

Alexandra J. D. Phelps, Calla Holmgren

Summary: The study aimed to assess the usage of low-dose aspirin by obstetrician-gynecologists for pregnant women at risk of hypertensive disorders of pregnancy, based on guidelines from the American College of Obstetricians and Gynecologists and the United States Preventive Services Task Force. It also evaluated prescribing practices in relation to specific risk factors to identify the women who are most likely to not receive the recommended therapy.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2023)

Add to Collection

Article Medicine, General & Internal

Clinical efficacy of low-dose aspirin combined with calcium in preventing preeclampsia: A systematic review and meta-analysis

Wen-Yue Chen, Su-Fang Sun

Summary: This systematic review and meta-analysis evaluated the clinical effectiveness of low-dose aspirin combined with calcium supplements for the prevention of preeclampsia. The results showed that compared with the control group, the experimental group had lower incidence rates of preeclampsia with gestational hypertension, preeclampsia, gestational hypertension, preterm birth, postpartum hemorrhage, and fetal growth restriction.

MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Estimated Prevalence of Risk Factors for Preeclampsia Among Individuals Giving Birth in the US in 2019

Sarahn M. Wheeler, Sabrena O. Myers, Geeta K. Swamy, Evan R. Myers

Summary: The study found that in 2019, out of 3,695,019 pregnancies in the United States, 528,778 had no risk factors, 169,540 had one or more high-risk factors, and 2,996,701 had one or more moderate-risk factors. Multifetal gestation was the most common high-risk factor, while low socioeconomic status was the most common moderate-risk factor. According to the 2021 criteria, 3,166,241 pregnant patients (85.7%) were eligible for LDA for preeclampsia prevention.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Obstetrics & Gynecology

Missed opportunities in aspirin prescribing for preeclampsia prevention

Noreen Singh, Saskia Shuman, Jacqueline Chiofalo, Mariela Cabrera, Aimee Smith

Summary: This study examines the association between preeclampsia risk factors and aspirin prescribing practices among patients receiving prenatal care at federally qualified health centers (FQHC). The findings indicate that only 39% of patients at risk for preeclampsia received an aspirin prescription.

BMC PREGNANCY AND CHILDBIRTH (2023)

Add to Collection

Article Obstetrics & Gynecology

Low-dose aspirin for prevention of preeclampsia: Implementation of the NICE guideline in Thailand

Manaphat Suksai, Alan Geater, Thitima Suntharasaj, Chitkasaem Suwanrath, Kla Charernjiratragul, Noppasin Khwankaew

Summary: This study evaluated the effectiveness of a preeclampsia (PE) screening program in pregnant Thai women using the NICE guideline. The results suggest that screening with the NICE guideline followed by low-dose aspirin prophylaxis may not be an effective strategy for preventing PE in this population.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2022)

Add to Collection

Review Obstetrics & Gynecology

Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis

Eleanor M. F. Richards, Veronica Giorgione, Oliver Stevens, Basky Thilaganathan

Summary: This systematic review and meta-analysis aimed to investigate the potential benefits of low-dose aspirin use during pregnancy in women with chronic hypertension. The analysis found that low-dose aspirin did not significantly reduce the odds of superimposed preeclampsia or poor perinatal outcomes. However, it did show a significant reduction in preterm birth.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Add to Collection

Article Obstetrics & Gynecology

Preeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation

Judette M. Louis, Jacqueline Parchem, Arthur Vaught, Martha Tesfalul, Anthony Kendle, Eleni Tsigas

Summary: Preeclampsia is a significant cause of perinatal and maternal morbidity and mortality, and its prevalence has been increasing. A virtual workshop was held to promote interdisciplinary collaborations and improve patient care for preeclampsia. The report summarizes the key findings and consensus-based recommendations from the workshop participants.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Low-Dose Aspirin after ASPRE-More Questions Than Answers? Current International Approach after PE Screening in the First Trimester

Piotr Tousty, Magda Fraszczyk-Tousty, Sylwia Dzidek, Hanna Jasiak-Jozwik, Kaja Michalczyk, Ewa Kwiatkowska, Aneta Cymbaluk-Ploska, Andrzej Torbe, Sebastian Kwiatkowski

Summary: Preeclampsia is a complex disorder of pregnancy with significant fetal and maternal consequences, and aspirin is recommended for high-risk women to reduce the risk. This review compared 14 guidelines and found variations in recommended dose, screening method, and timing for starting aspirin. Many societies now recommend higher doses (>75 mg) of aspirin, with most suggesting initiation before 16 weeks' gestation. The introduction of risk assessment models, such as the one proposed by the Fetal Medicine Foundation, has led to a shift in recommendations towards identifying high-risk populations and implementing aspirin prophylaxis, resulting in reduced morbidity for mothers and infants.

BIOMEDICINES (2023)

Add to Collection

Article Pharmacology & Pharmacy

Low- or high-dose preventive aspirin use and risk of death from all-cause, cardiovascular disease, and cancer: A nationally representative cohort study

Yu Chen, Fuli Chen, Jie Liao, Hukui Han, Gang Li, Long Zhou

Summary: This study aims to investigate the relationship between low- or high-dose preventive aspirin use and the risk of death among US adults. The results showed that low-dose aspirin use did not decrease the risk of death from any causes, while high-dose aspirin use increased the risk of cardiovascular disease death.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

Low-Dose Aspirin Prevents Kidney Damage in LPS-Induced Preeclampsia by Inhibiting the WNT5A and NF-κB Signaling Pathways

Guanlin Li, Wei Wei, Lingge Suo, Chun Zhang, Haiyan Yu, Hui Liu, Qing Guo, Xiumei Zhen, Yang Yu

Summary: The study demonstrated that aspirin treatment can effectively improve renal failure and pathological changes induced by preeclampsia, attenuating tubular injury and reducing kidney inflammation. It also suppresses renal cell apoptosis and oxidative stress. The mechanism involves inhibition of the WNT5A/NF-kappa B signaling pathway.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China

Li Lin, Jing Huai, Boya Li, Yuchun Zhu, Juan Juan, Meihua Zhang, Shihong Cui, Xianlan Zhao, Yuyan Ma, Yangyu Zhao, Yang Mi, Hongjuan Ding, Dunjin Chen, Weishe Zhang, Hongbo Qi, Xiaotian Li, Guanlin Li, Jiahui Chen, Huijing Zhang, Mengting Yu, Xiaotong Sun, Huixia Yang

Summary: The use of 100 mg aspirin for prevention of preeclampsia in high-risk pregnant women in China did not show significant efficacy.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Add to Collection

Letter Obstetrics & Gynecology

How to calculate the risk of preeclampsia in women with a history of positive screening

Paul Guerby, Emmanuel Bujold

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)

Add to Collection

Editorial Material Pediatrics

Early Detection and Prevention of Intrauterine Growth Restriction and Its Consequences

Paul Guerby, Emmanuel Bujold

JAMA PEDIATRICS (2020)

Add to Collection

Article Obstetrics & Gynecology

Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study

Amelie Boutin, Paul Guerby, Cedric Gasse, Sylvie Tapp, Emmanuel Bujold

Summary: This study aimed to estimate the incidence of placenta-mediated pregnancy complications in nulliparous women who received screening for preterm preeclampsia during early pregnancy. The results showed that the screening test by the Fetal Medicine Foundation could predict severe placenta-mediated pregnancy complications with reasonable accuracy.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Cell Biology

Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsia

Sarah Munchel, Suzanne Rohrback, Carlo Randise-Hinchliff, Sarah Kinnings, Shweta Deshmukh, Nagesh Alla, Catherine Tan, Amirali Kia, Grainger Greene, Linda Leety, Matthew Rhoa, Scott Yeats, Matthew Saul, Julia Chou, Kimberley Bianco, Kevin O'Shea, Emmanuel Bujold, Errol Norwitz, Ronald Wapner, George Saade, Fiona Kaper

SCIENCE TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Physiology

Study of sRAGE, HMGB1, AGE, and S100A8/A9 Concentrations in Plasma and in Serum-Extracted Extracellular Vesicles of Pregnant Women With Preterm Premature Rupture of Membranes

Damien Bouvier, Yves Giguere, Loic Blanchon, Emmanuel Bujold, Bruno Pereira, Nathalie Bernard, Denis Gallot, Vincent Sapin, Jean-Claude Forest

FRONTIERS IN PHYSIOLOGY (2020)

Add to Collection

Article Obstetrics & Gynecology

Mid-trimester microbial invasion of the amniotic cavity and the risk of preterm birth

Amelie Tetu, Paul Guerby, Fabien Rallu, Louise Duperron, Valerie Morin, Emmanuel Bujold

Summary: This study found no cases of mid-trimester MIAC in low-risk asymptomatic pregnant women using a combination of Mycoplasma-specific PCR and culture techniques. More sensitive and broad-range microbiologic techniques, such as 16S DNA detection by PCR, may need further evaluation.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Add to Collection

Review Obstetrics & Gynecology

Heparin for preventing adverse obstetrical outcomes in pregnant women with antiphospholipid syndrome, a systematic review and meta-analysis

Paul Guerby, Alexandre Fillion, Sarah O'Connor, Emmanuel Bujold

Summary: Heparin is effective in preventing adverse obstetrical outcomes in pregnant women with APS, increasing live birth rate and reducing the risk of preeclampsia without raising maternal and neonatal severe morbidity.

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2021)

Add to Collection

Article Medicine, General & Internal

Proteomic Analysis of Maternal Urine for the Early Detection of Preeclampsia and Fetal Growth Restriction

Emmanuel Bujold, Alexandre Fillion, Florence Roux-Dalvai, Marie Pier Scott-Boyer, Yves Giguere, Jean-Claude Forest, Clarisse Gotti, Genevieve Laforest, Paul Guerby, Arnaud Droit

Summary: This study demonstrated that maternal urine proteomic profiling can differentiate women with and without preeclampsia. Specific proteins like ceruloplasmin and serpin A7 were upregulated in maternal urine before the diagnosis of preeclampsia and fetal growth restriction, suggesting their potential role as biomarkers for early detection.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Obstetrics & Gynecology

First-Trimester Preterm Preeclampsia Screening in Nulliparous Women: The Great Obstetrical Syndrome (GOS) Study

Amelie Boutin, Cedric Gasse, Paul Guerby, Yves Giguere, Amelie Tetu, Emmanuel Bujold

Summary: The study found that a combination of multiple markers, including MAP, PlGF, AFP, and UtA-PI, can predict the risk of preterm preeclampsia in nulliparous women. The final model had an area under the curve of 0.84 and a detection rate of 55%.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2021)

Add to Collection

Article Obstetrics & Gynecology

A Pilot Randomized Trial Comparing the Effects of 80 versus 160 mg of Aspirin on Midtrimester Uterine Artery Pulsatility Index in Women with a History of Preeclampsia

Sylvie Tapp, Paul Guerby, Mario Girard, Stephanie Roberge, Stephane Cote, Ema Ferreira, Gregoire Leclair, Emmanuel Bujold

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2020)

Add to Collection

Article Obstetrics & Gynecology

Placental Growth Factor and Soluble, Fms-Like Tyrosine Kinase-1 in Preeclampsia: A Case-Cohort (PEARL) Study

Alexandre Fillion, Paul Guerby, Caroline Lachance, Marie-Pier Comeau, Marie-Claude Bussieres, Felicia-Allysson Doucet-Gingras, Sophie Zerounian, Suzanne Demers, Genevieve Laforest, Didier Menzies, Emmanuel Bujold

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2020)

Add to Collection

Article Obstetrics & Gynecology

Guideline No. 402: Diagnosis and Management of Placenta Previa

Venu Jain, Hayley Bos, Emmanuel Bujold

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2020)

Add to Collection

Article Obstetrics & Gynecology

Placenta previa: Diagnosis and Management

Venu Jain, Hayley Bos, Emmanuel Bujold

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2020)

Add to Collection

Article Obstetrics & Gynecology

First Trimester Mean Arterial Pressure Measured Manually Versus Using an Automated Device and the Prediction of Preeclampsia: A Case-Cohort Study

Maxime Cote, Amelie Boutin, Cedric Gasse, Suzanne Demers, Emmanuel Bujold

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2020)

Add to Collection

Article Obstetrics & Gynecology

Evolution of Down Syndrome Prenatal Screening Clinical Practices in Quebec

Audree Gareau-Leonard, Alexandre Fillion, Laurence Labine, Cedric Gasse, Suzanne Demers, Emmanuel Bujold

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2020)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.